VERU INC. Ratio of Indebtedness to Net Capital
VERU INC. (VERU) had Ratio of Indebtedness to Net Capital of 6500.00% as of 2017-09-30, per its 10-K filed 2018-01-02.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:RatioOfIndebtednessToNetCapital1 · last filed 2018-01-02
- 2017-09-30: Ratio of Indebtedness to Net Capital 6500.00%.
- 2015-09-30: Ratio of Indebtedness to Net Capital 10000.00%.
- 2015-06-30: Ratio of Indebtedness to Net Capital 100.00%.
- 2015-03-31: Ratio of Indebtedness to Net Capital 100.00%.
| Period end | Ratio of Indebtedness to Net Capital |
|---|---|
| 2017-09-30 | 6500.00% 10-K · filed 2018-01-02 |
| 2015-09-30 | 10000.00% 10-K · filed 2015-12-02 |
| 2015-06-30 | 100.00% 10-Q · filed 2015-07-30 |
| 2015-03-31 | 100.00% 10-Q · filed 2015-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |